These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 7678936)

  • 21. Location of 72-kd metalloproteinase (type IV collagenase) in untreated prostatic adenocarcinoma.
    Montironi R; Fabris G; Lucarini G; Biagini G
    Pathol Res Pract; 1995 Nov; 191(11):1140-6. PubMed ID: 8822116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: a stem cell model.
    Bonkhoff H; Remberger K
    Prostate; 1996 Feb; 28(2):98-106. PubMed ID: 8604398
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Androgen receptor expression in prostate cancer lymph node metastases is predictive of outcome after surgery.
    Sweat SD; Pacelli A; Bergstralh EJ; Slezak JM; Cheng L; Bostwick DG
    J Urol; 1999 Apr; 161(4):1233-7. PubMed ID: 10081876
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Telomerase reverse transcriptase subunit immunoreactivity: a marker for high-grade prostate carcinoma.
    Iczkowski KA; Pantazis CG; McGregor DH; Wu Y; Tawfik OW
    Cancer; 2002 Dec; 95(12):2487-93. PubMed ID: 12467061
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Androgen receptor expression in prostatic intraepithelial neoplasia and cancer.
    Sweat SD; Pacelli A; Bergstralh EJ; Slezak JM; Bostwick DG
    J Urol; 1999 Apr; 161(4):1229-32. PubMed ID: 10081875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Caspase 3 expression in benign prostatic hyperplasia and prostate carcinoma.
    O'Neill AJ; Boran SA; O'Keane C; Coffey RN; Hegarty NJ; Hegarty P; Gaffney EF; Fitzpatrick JM; Watson RW
    Prostate; 2001 May; 47(3):183-8. PubMed ID: 11351347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of the cyclin-dependent kinase inhibitor p27(Kip1) protein in human prostate cancer correlates with tumor grade.
    Guo Y; Sklar GN; Borkowski A; Kyprianou N
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2269-74. PubMed ID: 9815624
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of galactosyltransferase in prostatic tumors.
    Amselgruber WM; Sinowatz F; Kölle S; Lincoln DT; Kayser K
    Nutrition; 1995; 11(5 Suppl):638-42. PubMed ID: 8748240
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of cyclooxygenase-2 in prostate adenocarcinoma and benign prostatic hyperplasia.
    Lee LM; Pan CC; Cheng CJ; Chi CW; Liu TY
    Anticancer Res; 2001; 21(2B):1291-4. PubMed ID: 11396201
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ki-67 antigen and P53 protein expression in benign and malignant prostatic lesions. Immunohistochemical quantitative study.
    Sasor A; Wagrowska-Danilewicz M; Danilewicz M
    Pol J Pathol; 2000; 51(1):31-6. PubMed ID: 10833901
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum and plasma M(r) 92,000 progelatinase levels correlate with spontaneous metastasis of rat 13762NF mammary adenocarcinoma.
    Nakajima M; Welch DR; Wynn DM; Tsuruo T; Nicolson GL
    Cancer Res; 1993 Dec; 53(23):5802-7. PubMed ID: 8242639
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential expression of the estrogen receptor beta (ERbeta) in human prostate tissue, premalignant changes, and in primary, metastatic, and recurrent prostatic adenocarcinoma.
    Fixemer T; Remberger K; Bonkhoff H
    Prostate; 2003 Feb; 54(2):79-87. PubMed ID: 12497580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of canine basal cells in postnatal prostatic development, induction of hyperplasia, and sex hormone-stimulated growth; and the ductal origin of carcinoma.
    Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
    Prostate; 2001 Aug; 48(3):210-24. PubMed ID: 11494337
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of canine basal cells in prostatic post natal development, induction of hyperplasia, sex hormone-stimulated growth; and the ductal origin of carcinoma.
    Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
    Prostate; 2001 May; 47(3):149-63. PubMed ID: 11351344
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunocytochemical detection of matrix metalloproteinase expression in prostate cancer.
    Bodey B; Bodey B; Siegel SE; Kaiser HE
    In Vivo; 2001; 15(1):65-70. PubMed ID: 11286132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alpha-methylacyl-CoA racemase (P504S) expression in evolving carcinomas within benign prostatic hyperplasia and in cancers of the transition zone.
    Leav I; McNeal JE; Ho SM; Jiang Z
    Hum Pathol; 2003 Mar; 34(3):228-33. PubMed ID: 12673556
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of primary tumour site by immunolocalization of progastricsin in metastatic adenocarcinoma.
    Reid WA; Branch T; Gorman C; Kay J
    J Pathol; 1990 Mar; 160(3):203-7. PubMed ID: 2110593
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Levels of expression of p27KIP1 protein in human prostate and prostate cancer: an immunohistochemical analysis.
    Erdamar S; Yang G; Harper JW; Lu X; Kattan MW; Thompson TC; Wheeler TM
    Mod Pathol; 1999 Aug; 12(8):751-5. PubMed ID: 10463475
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunohistochemical study of the expression of epidermal growth factor receptor in benign prostatic hypertrophy, prostatic intraepithelial neoplasia and prostatic carcinoma.
    Rana S; Sen R; Kalra R; Arora B; Sharma P; Gahlawat S
    Indian J Pathol Microbiol; 2006 Oct; 49(4):495-9. PubMed ID: 17183836
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loss of type IV collagen alpha 5 and alpha 6 chains in human invasive prostate carcinomas.
    Dehan P; Waltregny D; Beschin A; Noel A; Castronovo V; Tryggvason K; De Leval J; Foidart JM
    Am J Pathol; 1997 Oct; 151(4):1097-104. PubMed ID: 9327743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.